Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Amrad Acquires Diagnostic Firm For A$50M In Cash, Stock

Feb. 25, 1998

HIV Drug Developer Frustrated; Pursuing Studies In China

Feb. 25, 1998

Peptech Making Changes; Returning To Australia

Feb. 25, 1998

Lilly To Pay Xenova $35M For Heart Attack Drug

Feb. 25, 1998

Gene Found That Keeps Female Embryos Female

Feb. 25, 1998

Genset's Revenues Double; But R&D Spending Widens '97 Loss

Feb. 25, 1998

Canadian Biotech Groups Merge To Form National Body

Feb. 25, 1998

Scientists Report Progress In Gene Disease Research

Feb. 18, 1998

Biota Licenses Potential Drug For Alzheimer's Disease

Feb. 18, 1998

CSL Boosts Half-Year Profit To A$14M, An 11 Percent Jump

Feb. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...